No video

How do you choose which Car T cell product to use?

  Рет қаралды 428

HealthTree University for Multiple Myeloma

HealthTree University for Multiple Myeloma

Күн бұрын

Пікірлер: 1
@BUY_YOUTUB_VIEWS_47
@BUY_YOUTUB_VIEWS_47 8 ай бұрын
Love this improvement
Is it possible to predict who are the patients who might have that delayed neurotoxicity?
9:38
HealthTree University for Multiple Myeloma
Рет қаралды 355
TECVAYLI (Teclistamab) Everything You Need to Know
22:21
HealthTree University for Multiple Myeloma
Рет қаралды 6 М.
Primary and secondary endpoints in a clinical trial | What are they?
4:13
HealthTree University for Multiple Myeloma
Рет қаралды 1,6 М.
All About Darzalex (daratumumab)
14:28
HealthTree University for Multiple Myeloma
Рет қаралды 7 М.
Probing the Myeloma Immune MicroEnvironment One Cell at A Time (Single-Cell Sequencing)
58:44
HealthTree Foundation for Multiple Myeloma
Рет қаралды 1,4 М.
What is randomisation?
3:52
Australian Clinical Trials Alliance
Рет қаралды 30 М.
How are bispecific antibodies be used in combination with other anti Myeloma therapies?
4:03
HealthTree University for Multiple Myeloma
Рет қаралды 222
CAR-T Cell Therapy VS Transplant | Rahul Banerjee, MD | TANDEM 2022
8:52
HealthTree Foundation for Multiple Myeloma
Рет қаралды 1,6 М.
All About TALVEY (talquetamab)
28:40
HealthTree University for Multiple Myeloma
Рет қаралды 2,3 М.
What is the future of clinical trials?
7:58
HealthTree University for Multiple Myeloma
Рет қаралды 238
Surrogate endpoints | What do they mean?
7:34
HealthTree University for Multiple Myeloma
Рет қаралды 468
CAR T-Cell Therapy: How Does It Work?
2:21
Dana-Farber Cancer Institute
Рет қаралды 470 М.